Nisa Investment Advisors’s Collegium Pharmaceutical COLL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $69.4K | Sell |
2,099
-1
| -0% | -$42 | ﹤0.01% | 1551 |
|
|
2025
Q4 | $97.2K | Sell |
2,100
-169
| -7% | -$7.07K | ﹤0.01% | 1445 |
|
|
2025
Q3 | $79.4K | Buy |
2,269
+34
| +2% | +$1.18K | ﹤0.01% | 1502 |
|
|
2025
Q2 | $66.1K | Buy |
2,235
+45
| +2% | +$1.28K | ﹤0.01% | 1521 |
|
|
2025
Q1 | $65.4K | Sell |
2,190
-303
| -12% | -$9.26K | ﹤0.01% | 1512 |
|
|
2024
Q4 | $71.4K | Buy |
2,493
+316
| +15% | +$10.5K | ﹤0.01% | 1570 |
|
|
2024
Q3 | $84.1K | Buy |
2,177
+19
| +0.9% | +$678 | ﹤0.01% | 1493 |
|
|
2024
Q2 | $69.5K | Buy |
2,158
+24
| +1% | +$832 | ﹤0.01% | 1565 |
|
|
2024
Q1 | $82.8K | Buy |
2,134
+31
| +1% | +$1.08K | ﹤0.01% | 1522 |
|
|
2023
Q4 | $64.7K | Hold |
2,103
| – | – | ﹤0.01% | 1566 |
|
|
2023
Q3 | $47K | Hold |
2,103
| – | – | ﹤0.01% | 1742 |
|
|
2023
Q2 | $45.2K | Hold |
2,103
| – | – | ﹤0.01% | 1782 |
|
|
2023
Q1 | $50K | Sell |
2,103
-320
| -13% | -$8.49K | ﹤0.01% | 1716 |
|
|
2022
Q4 | $56K | Hold |
2,423
| – | – | ﹤0.01% | 1732 |
|
|
2022
Q3 | $43K | Buy |
2,423
+33
| +1% | +$582 | ﹤0.01% | 1794 |
|
|
2022
Q2 | $42K | Buy |
2,390
+1,950
| +443% | +$32.8K | ﹤0.01% | 1787 |
|
|
2022
Q1 | $9K | Sell |
440
-4,359
| -91% | -$82.4K | ﹤0.01% | 2225 |
|
|
2021
Q4 | $86K | Sell |
4,799
-3,156
| -40% | -$61.5K | ﹤0.01% | 1572 |
|
|
2021
Q3 | $157 | Buy |
7,955
+7,335
| +1,183% | +$159K | ﹤0.01% | 1503 |
|
|
2021
Q2 | $15 | Hold |
620
| – | – | ﹤0.01% | 2172 |
|
|
2021
Q1 | $15 | Hold |
620
| – | – | ﹤0.01% | 2161 |
|
|
2020
Q4 | $12K | Sell |
620
-2,492
| -80% | -$48.7K | ﹤0.01% | 2187 |
|
|
2020
Q3 | $65K | Buy |
3,112
+2,392
| +332% | +$43.2K | ﹤0.01% | 1696 |
|
|
2020
Q2 | $13K | Sell |
720
-145
| -17% | -$2.84K | ﹤0.01% | 1860 |
|
|
2020
Q1 | $14K | Hold |
865
| – | – | ﹤0.01% | 1783 |
|
|
2019
Q4 | $18K | Sell |
865
-7,655
| -90% | -$128K | ﹤0.01% | 1710 |
|
|
2019
Q3 | $98K | Buy |
+8,520
| New | +$97.3K | ﹤0.01% | 1461 |
|
Other funds holding COLL
EAM
VCM
